FDA Inspection 1237108 — Regional Women's Health Group, LLC

Regional Women's Health Group, LLC — FEI 3004088908

The FDA completed an inspection of Regional Women's Health Group, LLC on Apr 29, 2024 in Marlton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 29, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Marlton, NJ (United States)

Citations

IDCFRDescription
1227221 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results
1228621 CFR 1271.80(b)Specimen collections not timely
1249221 CFR 1271.85(a)Infection with communicable disease agents

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.